Receptor associated protein (RAP) conjugates

Details Receptor associated protein (RAP) conjugates Receptor associated protein (RAP) conjugates

2009-07-24

2010-11-09

Kolker, Daniel E. (Department: 1649)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C424S649000

Reexamination Certificate

active

07829537

ABSTRACT:
The present invention is directed to a methods and compositions for receptor mediated drug delivery, particularly across the blood-brain barrier.

REFERENCES:
patent: 4018884 (1977-04-01), Cleeland, Jr. et al.
patent: 4391904 (1983-07-01), Litman et al.
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4744981 (1988-05-01), Pavanasasivam
patent: 4897255 (1990-01-01), Fritzberg et al.
patent: 4988496 (1991-01-01), Srinivasan et al.
patent: 5106951 (1992-04-01), Morgan, Jr. et al.
patent: 5186941 (1993-02-01), Callahan et al.
patent: 5474766 (1995-12-01), Schwartz et al.
patent: 5604198 (1997-02-01), Poduslo et al.
patent: 5650391 (1997-07-01), Schwartz et al.
patent: 5962012 (1999-10-01), Lin et al.
patent: 5962266 (1999-10-01), White et al.
patent: 5981194 (1999-11-01), Jeffries et al.
patent: 6072041 (2000-06-01), Davis et al.
patent: 6165476 (2000-12-01), Strom et al.
patent: 6261595 (2001-07-01), Stanley et al.
patent: 6426208 (2002-07-01), Kakkis et al.
patent: 6447775 (2002-09-01), Strickland et al.
patent: 6455494 (2002-09-01), Jefferies et al.
patent: 6569661 (2003-05-01), Qin et al.
patent: 6585971 (2003-07-01), Kakkis
patent: 6743427 (2004-06-01), Schenk
patent: 6919311 (2005-07-01), Lenting et al.
patent: 7122353 (2006-10-01), Shen
patent: 7700554 (2010-04-01), Beliveau et al.
patent: 2001/0025026 (2001-09-01), Heartlein et al.
patent: 2002/0168370 (2002-11-01), McDonald et al.
patent: 2003/0129186 (2003-07-01), Beliveau et al.
patent: 2004/0009906 (2004-01-01), Kakkis et al.
patent: 2007/0083334 (2007-04-01), Mintz et al.
patent: WO-00/04926 (2000-02-01), None
patent: WO-00/28021 (2000-05-01), None
patent: WO-00/71714 (2000-11-01), None
patent: WO-01/59459 (2001-08-01), None
patent: WO-02/13843 (2002-02-01), None
patent: WO-03/009815 (2003-02-01), None
Albeck et al., “A non-invasive transport system for GDNF across the blood-brain barrier”,NeuroReport, 8:2293-8 (1997).
Altschul et al., “Basic local alignment search tool”,J. Mol. Biol., 215:403-10 (1990).
Anderson et al., “Differential binding of ligands to the apolipoprotein E receptor 2,”Biochemistry, 42:9355-64 (2003).
Anderson et al., “Dominant thermodynamic role of the third independent receptor binding site in the receptor-associated protein RAP,”Biochemistry, 40:15408-17 (2001).
Anderson et al., “Identification of the minimal funcational unit in the low density lipoprotein receptor-related protein for binding the receptor-associated protein (RAP),”J. Biol. Chem., 275:21017-24 (2000).
Ashcom et al., “The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin”,J. Cell. Biol., 110:1041-8 (1990).
Bajari et al., “A minimal binding domain of the low density lipoprotein receptor family,”Biol. Chem., 379:1053-62 (1998).
Bickel et al., “Delivery of peptides and proteins through the blood-brain barrier”,Adv. Drug Deliv. Rev., 46:247-79 (2001).
Bickel et al., “Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery,”Proc. Natl. Acad. Sci. USA, 90:2618-22 (1993).
“BioMarin reports interim data on NeuroTrans brain delivery program”,Biotech Week, p. 3 (Jun. 19, 2002).
Blair et al., “Linkage of cytotoxic agents to immunoglobulins”,J. Immunol. Methods, 59:129-43 (1983).
Blattler et al., “New heterobifunctional protein crosslinking reagent that forms an acid-labile link”,Biochem., 24:1517-24 (1985).
Bogan et al., “Anatomy of hot spots in protein interfaces,”J. Mol. Biol., 280:1-9 (1998).
Bu et al., “RAP, a novel type of ER chaperone,”Trends Cell Biol., 8:272-6 (1998).
Bu et al., “Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein,”J. Biol. Chem., 271:22218-24 (1996).
Bu, “The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family,”Int. Rev. Cytol., 209:79-116 (2001).
Canals et al., “Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease”,J. Neurosci., 24:7727-39 (2004).
Christensen et al., “Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule”,Am. J. Physiol. Renal Physiol., 280:F562-73 (2001).
Clackson et al., “A hot spot of binding energy in a hormone-receptor interface,”Science, 267:383-6 (1995).
Czekay et al., “Endocytic trafficking of megalin/RAP complexes: dissociation of the complexes in late endosomes”,Mol. Biol. Cell., 8:517-32 (1997).
Dehouck et al., “A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier”,J. Cell Biol., 138:877-89 (1997).
Delano, “Unraveling hot spots in binding interfaces: progress and challenges,”Curr. Opin. Struct. Biol., 12:14-20 (2002).
Dwyer et al., “High affinity RNase S-peptide variants obtained by phage display have a novel hot-spot of binding energy,”Biochemistry, 40:13491-500 (2001).
Fahrlander et al., “Amplifying DNA probe signals: a ‘Christmas Tree’ approach”, Bio/Technology, 6:1165-1168 (1988).
Faucheux et al., “Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease”,Proc. Natl. Acad. Sci. USA, 92:9603-7 (1995).
Feng et al., “Progressive sequence alignment as a prerequisite to correct phylogenetic trees”,J. Mol. Evol., 25:351-60 (1987).
Ferrer et al., “Brain-derived neurotrophic factor in Huntington disease”,Brain Res., 866:257-61 (2000).
Fillebeen et al., “Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier,”J. Biol. Chem., 274:7011-7 (1999).
Fisher et al., “Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors”,Mol. Cell., 22:277-83 (2006).
Fitzgerald et al., “Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein”,J. Cell Biol., 129:1533-41 (1995).
Gao et al., “Structure-based method for analyzing protein-protein interfaces,”J. Mol. Model, 10:4-54 (2004).
GenBank accession No. AAH49517, Low density lipoprotein receptor-related protein associated protein 1 (printed Apr. 22, 2004).
GenBank accession No. AAM90301, low density lipoprotein receptor-related protein-associated protein 1, (printed Apr. 22, 2004).
GenBank accession No. CAA05085, receptor-associated protein [Gallus gallus] (printed Apr. 22, 2004).
GenBank accession No. NP—506187, hypothetical protein C15C8.4 [Caenorhabditis elegans] (printed May 21, 2004).
GenBank accession No. NP—649950, CG8507 [Drosophila melanogaster] (printed May 21, 2004).
GenBank accession No. P30533, low density lipoprotein receptor-related protein-associated protein 1 (printed Apr. 22, 2004).
GenBank accession No. Q99068, low density lipoprotein receptor-related protein-associated protein 1 (printed Apr. 22, 2004).
GenBank accession No. X13916, human mRNA for LDL-receptor related protein (printed Apr. 22, 2004).
GenBank Accession No. XP—132029, low density lipoprotein receptor-related protein associated protein 1 [Mus musculus] (printed May 21, 2004).
Genbank Accession No. XP—313261, AGAP003521-PA [Anopheles gambiaestr. PEST] (printed May 21, 2004).
Gutierrez et al., “Murine tumor necrosis factor alpha is transported from blood to brain in the mouse”,J. Neuroimmunology, 47(2):169-76 (1993).
Halperin et al., “Protein-protein interactions: coupling of structurally conserved residues and of hot spots across interfaces. Implications for docking”,Structure, 12:1027-38 (2004).
Henikoff et al., “Amino acid substitution matrices from protein blocks”,Proc. Na

Affiliated with

Also associated with

Rating

Receptor associated protein (RAP) conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Receptor associated protein (RAP) conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Receptor associated protein (RAP) conjugates will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4173281